Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine versus amitriptyline for migraine prophylaxis
IRCT20170814035697N6Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of venlafaxine and amitriptyline in migraine (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Number of migraine attacks, Severity of migraine attacks and 1 more. Started Jul 2020; status: completed.
02
Drugs
venlafaxineamitriptyline
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20170814035697N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170814035697N6.